GHRH and ischemia: The recent demonstrations by our group and others, respectively, that JI-38 markedly enhanced the functional properties and potential therapy by MSCs and cardiac stem cells in different models of ischemia raise the possibility that GHRH agonists may be useful agents to augment clinical cell therapy.